From Scientist to Analyst to Strategist

Ken Herrmann, MD, MBA, from the Universitätsklinikum Essen (Germany), and Johannes Czernin, MD, from the David Geffen School of Medicine at UCLA, talked with Aharon (Ronny) Gal, PhD, about his career across a range of scientific, analytic, consulting, and leadership positions. Dr. Gal is Chief

Authors

Ken Herrmann
Johannes Czernin
Aharon Gal

Institutions

Novartis (Switzerland) (CH)
University of California, Los Angeles (US)
Essen University Hospital (DE)

Publication Details

Journal: Journal of Nuclear Medicine
Published: 2025-01-16
DOI: https://doi.org/10.2967/jnumed.124.269177
Primary Topic: Health and Medical Research Impacts
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

From Scientist to Analyst to Strategist

Ken Herrmann, Johannes Czernin, Aharon Gal

Jan 16, 2025

Journal of Nuclear Medicine

Health and Medical Research Impacts

article

From Scientist to Analyst to Strategist

Ken Herrmann, Johannes Czernin, Aharon Gal

January 16, 2025article en

Abstract

Journal of Nuclear MedicineVol. 66(2)

Novartis (Switzerland) (CH), University of California, Los Angeles (US), Essen University Hospital (DE)

Openalex Percentile: Top 99%

Health and Medical Research Impacts

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

From Scientist to Analyst to Strategist — Ken Herrmann, Johannes Czernin, et al. · Journal of Nuclear Medicine (2025) | TGRS Research Map | TGRS